Krilogy Financial LLC Sarepta Therapeutics, Inc. Transaction History

Krilogy Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $29,195 - $44,628	-300 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $34,593 - $48,453	300 New	300 $48,000
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $18,907 - $28,794	-350 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$47.64 - $56.75 $9,528 - $11,350	-200 Reduced 36.36%	350 $19,000
Q3 2017 Nov 15, 2017	SELL	$35.73 - $47.15 $3,572 - $4,715	-100 Reduced 15.38%	550 $25,000
Q2 2017 Aug 15, 2017	BUY	N/A	650	650 $22,000

525

84.4M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Krilogy Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Krilogy Financial LLC with notifications on news.